10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001144204-18-044625`
Period End Date	20180630
Filing Date	20180814
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	bpth-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 52 Cash Flow Statement 50

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Cash	`Cash`	$6.18M	USD	Point-in-time
Cash	`Cash`	$5.96M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$2.58M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$1.12M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$1.33M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$353.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$604.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.43M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.51M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	11.34M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	11.34M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	11.34M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.00M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	11.34M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$984.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$462.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$330.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$654.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$539.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.81M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.73M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$689.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$769.00K	USD	Point-in-time
Total Assets	`Assets`	$8.86M	USD	Point-in-time
Total Assets	`Assets`	$5.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$137.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$868.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$739.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$791.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.00M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.00M	USD	Point-in-time
Total Liabilities	`Liabilities`	$791.00K	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 11,341 and 11,339 shares issued and outstanding, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 11,341 and 11,339 shares issued and outstanding, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$47.21M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$47.48M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-39.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-42.75M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.74M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.07M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$5.74M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$8.86M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.51M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.76M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.48M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$827.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.84M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$852.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$845.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.81M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.32M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.68M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.33M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.60M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-3.60M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.33M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.32M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.68M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-778.00K	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$5.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$340.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$5.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$1.94M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.59M	USD	2 Qtrs
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	$-1.04M	USD	1 Quarter
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	$-1.04M	USD	2 Qtrs
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$1.68M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$3.02M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$3.59M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$3.42M	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.71M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.34M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.86M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.34M	shares	2 Qtrs

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.59M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$80.00K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$80.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$132.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$108.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$263.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$507.00K	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-778.00K	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$215.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$216.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$251.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$109.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-257.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$214.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.20M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.37M	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$538.00K	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-538.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.00K	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$1.55M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.55M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-3.19M	USD	2 Qtrs
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-3.39M	USD	2 Qtrs
Cash, beginning of period	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of period	`Cash`	$6.18M	USD	Point-in-time
Cash, beginning of period	`Cash`	$5.96M	USD	Point-in-time
Cash, beginning of period	`Cash`	$2.58M	USD	Point-in-time
Cash, end of period	`Cash`	$9.38M	USD	Point-in-time
Cash, end of period	`Cash`	$6.18M	USD	Point-in-time
Cash, end of period	`Cash`	$5.96M	USD	Point-in-time
Cash, end of period	`Cash`	$2.58M	USD	Point-in-time
Warrants transferred to equity upon modification	`WarrantsTransferredToEquityUponModification`	$797.00K	USD	2 Qtrs
Warrants transferred to equity upon modification	`WarrantsTransferredToEquityUponModification`	-	USD	2 Qtrs
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	$175.00K	USD	2 Qtrs
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	-	USD	2 Qtrs
Offering expenses included in accrued expenses	`LiabilitiesAssumed1`	-	USD	2 Qtrs
Offering expenses included in accrued expenses	`LiabilitiesAssumed1`	$30.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.